Internal Medicine

3151 questions

Question 1121Question →

A 24-year-old woman is seen in the ambulatory care center for evaluation of easy bruising and frequent nosebleeds. She reports that her epistaxis occurs spontaneously and often requires up to 20 minutes of direct compression to resolve. Furthermore, she has experienced exceptionally heavy menstrual bleeding since menarche, frequently bleeding through super-absorbent tampons every 2 hours during the heaviest days of her cycle. Last month, a dental extraction was complicated by continuous mucosal oozing that persisted for 48 hours. She has no other medical conditions and does not take any prescription or over-the-counter medications. Her vital signs are within normal limits. Physical examination reveals several small ecchymoses on her bilateral lower extremities, but no petechiae, hemarthroses, or hepatosplenomegaly are noted. The physician suspects an underlying inherited bleeding diathesis.

Arrange the following steps in the diagnostic and management algorithm for this patient in the correct chronological sequence, from initial screening to therapeutic planning.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Initial coagulation screen (CBC, PT, aPTT), 2) Confirmatory factor assays (vWF antigen, ristocetin cofactor activity, factor VIII), 3) Subtype determination (vWF multimer analysis), and 4) Treatment planning (DDAVP trial).
The correct sequence follows the standard diagnostic and management algorithm for von Willebrand disease (vWD). First, an initial hemostatic screen (CBC, PT, aPTT) is required to rule out thrombocytopenia and other broad coagulation defects. Second, once the screen suggests a primary hemostatic defect, specific confirmatory quantitative and qualitative assays (vWF antigen, ristocetin cofactor activity, factor VIII) are performed. Third, after vWD is confirmed, a multimer analysis is conducted to determine the specific subtype (Type 1, 2, or 3), which dictates pathophysiology. Finally, a desmopressin (DDAVP) challenge is administered in a non-bleeding state to assess if the patient has a sufficient release of endogenous vWF and factor VIII, which establishes whether DDAVP can be safely and effectively utilized for future bleeding episodes or surgical prophylaxis.

Step-by-Step Solution

1
Perform initial hemostatic screening
Identifies a normal platelet count, normal prothrombin time, and potentially mildly prolonged aPTT.
Broadly categorizes the bleeding diathesis and rules out thrombocytopenia or factor deficiencies in the extrinsic/common pathways before pursuing specialized testing.
2
Perform confirmatory von Willebrand disease testing
Demonstrates quantitative or qualitative deficiencies in von Willebrand factor and secondary decreases in factor VIII.
Establishes the definitive diagnosis of von Willebrand disease based on the abnormal screening results and bleeding history.
3
Determine the disease subtype
Characterizes the size distribution of von Willebrand factor multimers.
Differentiates between quantitative defects (Type 1, 3) and qualitative defects (Type 2), which is clinically necessary for guiding specific therapies and avoiding contraindicated treatments.
4
Assess therapeutic responsiveness
Evaluates the patient's rise in von Willebrand factor and factor VIII following the administration of desmopressin (DDAVP).
Determines if DDAVP induces sufficient endogenous factor release to be used for future bleeding episodes or surgical prophylaxis.

Key Concept

Diagnostic and management sequence for von Willebrand disease
Estimated Time:1m 30s
Question 1122Question →

A 42-year-old woman is newly diagnosed with seropositive rheumatoid arthritis. She presents with symmetric polyarthritis involving the metacarpophalangeal and proximal interphalangeal joints, morning stiffness lasting 3 hours, and early marginal erosions on hand radiography. Assuming she experiences an initial inadequate clinical response to each successive pharmacological intervention, but eventually achieves and maintains deep remission, arrange the following management steps in the standard evidence-based sequence according to current treatment guidelines.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for rheumatoid arthritis management escalation is: initiation of methotrexate with bridging glucocorticoids, followed by the addition of a biologic DMARD (e.g., TNF inhibitor), then switching to a biologic with an alternative mechanism of action upon failure, and finally tapering the biologic once sustained remission is achieved.
The standard algorithm for managing rheumatoid arthritis follows a stepwise 'treat-to-target' approach. Phase 1 involves starting a conventional synthetic DMARD, universally methotrexate, alongside short-term bridging glucocorticoids to rapidly quell inflammation. If the patient has not reached the target of remission or low disease activity by 3 to 6 months (Phase 2), a biologic DMARD (such as a TNF inhibitor) is added to the background methotrexate. Should this first biologic fail (Phase 3), switching to an agent with an alternative mechanism of action (e.g., tocilizumab or rituximab) is indicated. Finally, once a patient achieves and maintains sustained deep remission for at least 6 months, cautious dose-reduction or interval-spacing of the biologic (Phase 4) is recommended to minimize cumulative toxicity and immunosuppression.

Step-by-Step Solution

1
Identify the initial treatment for newly diagnosed active rheumatoid arthritis.
Methotrexate plus short-term glucocorticoids is the standard first-line therapy.
This combination provides immediate symptom relief through systemic steroids while allowing time for the disease-modifying effects of methotrexate to take hold.
2
Determine the next step for a patient with an inadequate response to initial methotrexate.
Addition of a biologic DMARD (such as a TNF-alpha inhibitor).
When conventional synthetic DMARDs fail to achieve low disease activity or remission within 3 to 6 months, clinical guidelines recommend combining them with a biologic or targeted synthetic DMARD.
3
Determine the subsequent strategy if the first biologic agent fails.
Switch to a biologic with a different mechanism of action.
If a patient exhibits primary or secondary failure to one class of biologics (e.g., TNF inhibitors), switching to a different class (e.g., IL-6 inhibitors, anti-CD20) offers the best chance of establishing disease control.
4
Identify the management approach once deep, sustained remission is reached.
Cautious tapering (dose reduction or interval spacing) of the biologic agent.
To minimize long-term risks of immunosuppression and medication burden, treatment algorithms mandate attempting to cautiously de-escalate therapy after prolonged clinical remission is maintained.

Key Concept

The treat-to-target strategy in rheumatoid arthritis involves stepwise escalation from conventional synthetic DMARDs to biologic DMARDs, switching mechanisms upon failure, and eventually attempting cautious de-escalation once sustained remission is achieved.
Estimated Time:1m 30s
Question 1123Question →

Match each patient's clinical presentation with the most appropriate specific therapeutic intervention.

Click a left item, then click its matching right item

Items

A 42-year-old man on monotherapy for latent tuberculosis is brought in actively seizing. Seizures have persisted for 20 minutes despite adequate doses of intravenous midazolam and phenytoin. Laboratory testing reveals a profound unexplained metabolic acidosis.
A 68-year-old man with opioid use disorder maintained on a synthetic mu-opioid agonist is treated with a macrolide antibiotic for an upper respiratory infection. He presents with recurrent syncope. Telemetry shows bursts of wide-complex tachycardia with constantly changing amplitude around the isoelectric line.
A 55-year-old woman with recurrent depression, stably managed on a long-acting selective serotonin reuptake inhibitor, is hospitalized for a complex soft tissue infection and started on an oxazolidinone antibiotic. Within 48 hours, she develops severe agitation, diaphoresis, a temperature of 39.8°C (103.6°F), and spontaneous myoclonus.
A 34-year-old man managed for acute mania presents with profound confusion, a coarse intentional tremor, and new-onset ataxia after a recent bout of severe rotavirus diarrhea. His estimated glomerular filtration rate has acutely dropped to 25 mL/min/1.73m², and a specific serum drug assay returns at 4.6 mEq/L.
A 75-year-old woman with chronic systolic heart failure and atrial fibrillation presents with anorexia, vomiting, and fatigue. Her spouse notes she recently complained of a yellowish tint to her vision. Cardiac monitoring demonstrates bidirectional ventricular tachycardia, and serum potassium is 5.9 mEq/L.

Matches

Show answer & explanation

Answer

Latent TB/seizures matches Intravenous pyridoxine. Methadone/macrolide/polymorphic VT matches Intravenous magnesium sulfate. SSRI/linezolid/hyperthermia matches Oral cyproheptadine. Lithium tox/AKI matches Emergent hemodialysis. Heart failure/xanthopsia/bidirectional VT matches Digoxin-specific antibody fragments.
Each correct pairing links a complex toxicological presentation with its specific, life-saving intervention. Isoniazid depletes pyridoxine, leading to refractory seizures. Methadone and macrolides interact to cause QT prolongation and Torsades de pointes, treated with magnesium. Linezolid and SSRIs interact to cause serotonin syndrome, treated with cyproheptadine. Lithium toxicity > 4.0 mEq/L with AKI requires hemodialysis. Digoxin toxicity presenting with severe hyperkalemia and bidirectional VT requires specific antibody fragments.

Step-by-Step Solution

1
Analyze each patient's clinical presentation and medication history to identify the specific toxidrome or adverse drug reaction.
Patient 1 has isoniazid toxicity. Patient 2 has Torsades de pointes from QT-prolonging agents. Patient 3 has serotonin syndrome. Patient 4 has lithium toxicity. Patient 5 has digoxin toxicity.
Accurate recognition of life-threatening toxidromes based on nuanced historical clues is required before selecting an antidote.
2
Select the definitive, targeted therapy for each identified condition, bypassing generic algorithmic treatments that may be ineffective or harmful.
Pyridoxine for isoniazid seizures; magnesium for Torsades; cyproheptadine for serotonin syndrome; hemodialysis for severe lithium toxicity; and digoxin-specific antibodies for digoxin toxicity with hyperkalemia.
Toxicological emergencies often require specific antidotes or extracorporeal removal rather than standard supportive care.

Key Concept

Targeted management and antidote selection for complex, multi-drug or severe toxicological emergencies in internal medicine.
Question 1124Question →

A 41-year-old woman recently diagnosed with limited cutaneous systemic sclerosis seeks care for progressively worsening color changes and throbbing pain in her fingers upon cold exposure. Over several years, her symptoms progressively escalate despite compliance with each prescribed treatment regimen, eventually leading to severe digital ischemia and impending gangrene. Arrange the following therapies for secondary Raynaud phenomenon in the standard stepwise order of clinical escalation, from initial baseline management to interventions for medically refractory, limb-threatening disease.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence of therapy escalation is: behavioral modifications, followed by oral calcium channel blockers, followed by oral PDE-5 inhibitors, then intravenous prostanoids, and finally digital sympathectomy.
The management of secondary Raynaud phenomenon follows a strict stepwise escalation to balance efficacy with medication side effects and procedural risks. Treatment always begins with nonpharmacologic behavioral modifications. If vasospastic attacks continue, oral vasodilators are introduced, starting with dihydropyridine calcium channel blockers. If symptoms remain refractory, secondary oral agents like PDE-5 inhibitors are added. Progression to severe ischemic complications, such as digital ulcers, mandates escalation to intravenous prostanoids. Finally, if tissue loss is imminent and all medical therapies fail, surgical sympathectomy is performed.

Step-by-Step Solution

1
Identify the initial baseline management for Raynaud phenomenon.
Behavioral modifications are selected as the first step.
Keeping the core and extremities warm while avoiding triggers like smoking is a mandatory, non-invasive baseline for all patients.
2
Determine the first-line pharmacologic escalation.
Oral dihydropyridine calcium channel blockers are selected as the second step.
When non-pharmacologic measures fail, calcium channel blockers like nifedipine are the safest and most effective initial oral vasodilators.
3
Identify the next step for inadequate response to initial pharmacotherapy.
Addition of a PDE-5 inhibitor is selected as the third step.
Additional oral agents such as sildenafil are added to maximize vasodilation before resorting to invasive or intravenous options.
4
Determine the management for severe complications like digital ulcers.
Intravenous prostanoids are selected as the fourth step.
Active tissue ischemia or ulceration demands potent, systemic therapies like intravenous epoprostenol.
5
Identify the treatment of last resort for limb-threatening disease.
Digital sympathectomy is selected as the final step.
Surgical intervention is highly invasive and is reserved for imminent gangrene when all medical therapies have been exhausted.

Key Concept

Stepwise escalation of therapy for secondary Raynaud phenomenon in systemic sclerosis.
Question 1125Question →

For each patient presentation describing a new diagnosis of primary hypertension with specific comorbidities, select the most appropriate preferred initial antihypertensive medication class.

Click a left item, then click its matching right item

Items

A 62-year-old female with a recent dual-energy x-ray absorptiometry scan indicating significant bone mineral density loss.
A 55-year-old male with chronic kidney disease and a urine albumin-to-creatinine ratio of 400 mg/g.
A 45-year-old female who reports frequent, painful episodes of digital pallor and cyanosis when exposed to cold environments.
A 50-year-old male with a history of an anterior wall myocardial infarction three months ago and a left ventricular ejection fraction of 40%.

Matches

Show answer & explanation

Answer

Osteoporosis is treated with a Thiazide diuretic; CKD with albuminuria is treated with an ACE inhibitor; Raynaud phenomenon is treated with a Dihydropyridine calcium channel blocker; and prior MI is treated with a Beta-adrenergic antagonist.
Each patient's presentation includes a specific comorbidity that dictates a preferred antihypertensive class based on secondary therapeutic benefits and established mortality reduction guidelines.

Step-by-Step Solution

1
Identify the primary compelling indication or comorbidity in each patient's presentation.
Patient 1 has osteoporosis. Patient 2 has CKD with overt albuminuria. Patient 3 has Raynaud phenomenon. Patient 4 has a prior myocardial infarction with reduced ejection fraction.
Current hypertension guidelines recommend tailoring initial medical therapy based on specific comorbid conditions to maximize therapeutic benefit.
2
Match each identified comorbidity to the antihypertensive class that provides the most advantageous secondary benefit or mortality reduction.
Osteoporosis benefits from thiazides due to calcium retention. CKD with albuminuria requires ACE inhibitors for renoprotection. Raynaud phenomenon improves with the vasodilatory effects of dihydropyridines. A prior MI requires beta-blockers to reduce cardiac workload and improve survival.
Selecting the optimal pharmacological agent requires synthesizing the diagnosis with the pleiotropic effects of the medication.

Key Concept

Tailoring initial antihypertensive therapy based on compelling clinical indications and patient-specific comorbidities.
Question 1126Question →

During a scheduled wellness examination, a 72-year-old male mentions to his physician that his daily neighborhood walks have become increasingly difficult over the last three months due to profound fatigue. He has no prior history of cardiopulmonary disease and denies melena, hematochezia, changes in bowel habits, or abdominal pain. Vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 135/82 mm Hg, pulse 86/min, and respirations 14/min. Physical examination demonstrates noticeable conjunctival pallor. The abdomen is soft and non-tender without hepatosplenomegaly.

Laboratory evaluation reveals the following:

TestResultReference Range
Hemoglobin9.1 g/dL13.5-17.5 g/dL
Mean corpuscular volume (MCV)73 fL80-100 fL
Leukocyte count6,500/mm3^34,500-11,000/mm3^3
Platelet count410,000/mm3^3150,000-400,000/mm3^3
Serum iron25 μ\mug/dL65-175 μ\mug/dL
Total iron-binding capacity (TIBC)460 μ\mug/dL250-400 μ\mug/dL
Serum ferritin9 ng/mL20-250 ng/mL

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Referral for colonoscopy and esophagogastroduodenoscopy

Answer

Referral for colonoscopy and esophagogastroduodenoscopy is the correct next step to evaluate for gastrointestinal malignancy.
The correct answer is referral for colonoscopy and esophagogastroduodenoscopy. This patient presents with laboratory findings pathognomonic for iron deficiency anemia (microcytosis, low serum iron, high total iron-binding capacity, and low ferritin). In adult men and postmenopausal women, the most common and critical cause of iron deficiency is occult gastrointestinal blood loss. Because gastrointestinal malignancies (such as colorectal carcinoma) can present solely with iron deficiency anemia prior to the onset of bowel symptoms or overt bleeding, bidirectional endoscopy is mandatory to rule out cancer.

Step-by-Step Solution

1
Analyze the complete blood count and iron studies.
The patient has a microcytic anemia (MCV 73 fL) with low serum iron, high TIBC, and low ferritin (9 ng/mL).
To establish the specific etiology of the patient's anemia, which clearly indicates iron deficiency.
2
Determine the clinical significance of iron deficiency in this specific demographic.
In an elderly male, iron deficiency anemia is highly suspicious for chronic gastrointestinal blood loss.
To recognize that unlike in menstruating women, iron deficiency in older adults is rarely due to physiologic blood loss or pure dietary deficiency.
3
Select the appropriate diagnostic intervention.
Bidirectional gastrointestinal endoscopy (colonoscopy and esophagogastroduodenoscopy) is indicated.
To rule out occult gastrointestinal malignancies, such as colon cancer, which are the most critical, life-threatening causes of occult blood loss in this age group.

Key Concept

In adult males and postmenopausal females, new-onset iron deficiency anemia must be presumed to be caused by gastrointestinal bleeding (often occult malignancy) until proven otherwise, necessitating endoscopic evaluation.
Estimated Time:1m 0s
Question 1127Question →

A 6868-year-old man is admitted to the general medical floor with a 44-day history of fever, chills, and a cough productive of rust-colored sputum. His past medical history is significant only for benign prostatic hyperplasia. He has not had any recent hospitalizations, does not reside in a nursing facility, and has not received any antibiotics in the past year. Vital signs on presentation include a temperature of 38.8∘C38.8^{\circ}\text{C} (101.8∘F101.8^{\circ}\text{F}), blood pressure of 115/76 mm Hg115/76\text{ mm Hg}, pulse of 102/min102/\text{min}, and respiratory rate of 24/min24/\text{min}. Oxygen saturation is 94%94\% on 2 L/min2\text{ L/min} via nasal cannula. Chest radiography demonstrates a dense consolidation in the left lower lobe. The admitting physician empirically prescribes intravenous piperacillin-tazobactam and vancomycin. A high-quality sputum Gram stain demonstrates many polymorphonuclear leukocytes and abundant Gram-positive diplococci. Which of the following is the most appropriate modification to this patient's antimicrobial regimen?

Show answer & explanation

Answer: Switch to intravenous ceftriaxone and oral azithromycin

Answer

Switch to intravenous ceftriaxone and oral azithromycin
This patient presents with a classic clinical picture of community-acquired pneumonia (CAP), highly likely due to Streptococcus pneumoniae given the rust-colored sputum and characteristic Gram-positive diplococci on Gram stain. Because he has no recent healthcare exposure, prior antibiotic use, or structural lung disease, he lacks risk factors for multidrug-resistant organisms such as methicillin-resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa. Therefore, the empiric use of piperacillin-tazobactam and vancomycin in the emergency department was inappropriately broad. Principles of antibiotic stewardship dictate that therapy should be promptly de-escalated. The standard empiric treatment for a patient admitted to the medical ward for CAP is a beta-lactam (e.g., ceftriaxone, cefotaxime) combined with a macrolide (e.g., azithromycin) to cover both typical and atypical pathogens. Transitioning to this regimen provides optimal coverage while minimizing the risk of adverse drug events and antimicrobial resistance.

Step-by-Step Solution

1
Identify the primary clinical syndrome.
The patient's acute fever, productive cough, focal consolidation on radiography, and Gram-positive diplococci on sputum stain point to typical community-acquired pneumonia (CAP), most likely caused by Streptococcus pneumoniae.
Establishing the correct diagnosis guides the selection of empiric pharmacotherapy.
2
Assess the patient for risk factors for multidrug-resistant (MDR) organisms.
The patient resides in the community, has not been hospitalized recently, and has not received prior antibiotics, meaning he is at very low risk for Pseudomonas aeruginosa or methicillin-resistant Staphylococcus aureus (MRSA).
Risk stratification determines whether broad-spectrum antibiotics are warranted.
3
Evaluate the current therapeutic regimen against principles of antibiotic stewardship.
Piperacillin-tazobactam and vancomycin provide excessively broad coverage that is unwarranted for this patient, exposing him to unnecessary risks of toxicity and resistance.
Initial empiric regimens often need to be de-escalated once a patient's risk profile and preliminary data (like Gram stains) are reviewed.
4
Select the optimal standard regimen for inpatient CAP.
A beta-lactam (like ceftriaxone) combined with a macrolide (like azithromycin) provides appropriate coverage for typical pathogens (e.g., S. pneumoniae) and atypical pathogens (e.g., Mycoplasma, Legionella).
This combination represents standard-of-care empiric therapy for non-severe inpatient CAP without MDR risk factors.

Key Concept

Antibiotic stewardship in community-acquired pneumonia requires avoiding broad-spectrum agents targeting MRSA and Pseudomonas aeruginosa unless specific epidemiological risk factors are present, and instead utilizing targeted regimens like a beta-lactam plus a macrolide.
Question 1128Question →

An athletic 24-year-old male construction worker presents with an 8-month history of insidious-onset lower back pain and severe morning stiffness. He reports that the stiffness often lasts for over an hour after awakening but gradually improves as he engages in physical labor throughout the day. His symptoms frequently awaken him in the second half of the night. He denies any radiating leg pain, numbness, or bowel/bladder dysfunction. Physical examination reveals a restricted range of motion in the lumbar spine, as evidenced by a modified Schober test expansion of only 3 cm3\text{ cm} (normal >5 cm>5\text{ cm}). Neurologic examination of the lower extremities is unremarkable.

Assuming the patient's initial imaging studies do not yield a definitive diagnosis and his symptoms remain unacceptably high despite initial interventions, arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for establishing the diagnosis and managing this patient according to standard rheumatologic guidelines.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Plain radiography -> MRI of sacroiliac joints -> Continuous NSAID therapy -> Assessment after 2-4 weeks -> TNF-alpha inhibitor therapy.
The patient presents with classic features of inflammatory back pain (insidious onset, morning stiffness lasting >1 hour>1\text{ hour}, improvement with exercise, nighttime awakening), highly suspicious for axial spondyloarthritis (axSpA). The standard chronological approach begins with plain radiography of the sacroiliac joints to look for definitive structural damage. Because early disease often lacks radiographic changes, an MRI of the sacroiliac joints is the required next step if X-rays are negative or equivocal, as it can detect active osteitis. Once the diagnosis is established, the first-line pharmacologic intervention is a continuous, scheduled trial of NSAIDs. If the patient has persistently high disease activity upon reassessment after at least 22 to 44 weeks of continuous NSAID therapy, escalation to a biologic agent, such as a TNF-alpha inhibitor, is indicated.

Step-by-Step Solution

1
Select plain radiography of the sacroiliac joints as the initial step.
Initial assessment for structural damage is performed.
Guidelines require plain X-rays first due to wide availability and the ability to immediately establish a diagnosis of radiographic axial spondyloarthritis if classic changes are present.
2
Select MRI of the sacroiliac joints as the second step.
Detection of active osteitis/bone marrow edema.
In early disease, X-rays are often negative. MRI is required to diagnose non-radiographic axial spondyloarthritis when X-rays are non-diagnostic but clinical suspicion remains high.
3
Select the initiation of a continuous, scheduled NSAID course as the third step.
First-line pharmacotherapy is established.
Once diagnosis is confirmed, NSAIDs given at full anti-inflammatory doses on a continuous schedule (rather than PRN) are the primary treatment for axial spondyloarthritis.
4
Select the reassessment of disease activity after 2 to 4 weeks as the fourth step.
Verification of treatment failure or success.
A documented failure of a continuous NSAID trial is a strict prerequisite before escalating to more aggressive, expensive immunosuppressive therapies.
5
Select the initiation of a TNF-alpha inhibitor as the final step.
Escalation to second-line biologic therapy.
Biologic agents (like TNF or IL-17 inhibitors) are strictly reserved for patients with active disease who have failed to respond adequately to continuous NSAIDs.

Key Concept

The diagnostic and therapeutic escalation pathway for axial spondyloarthritis requires a stepwise approach: initial plain films followed by MRI if negative, then continuous NSAIDs as first-line therapy, culminating in biologic agents only if NSAIDs fail after a defined trial period.
Question 1129Question →

A 27-year-old woman is brought to the emergency department due to a 2-day history of progressively worsening shortness of breath, fever, and coughing up blood-tinged sputum. She has a history of systemic lupus erythematosus (SLE) complicated by class IV lupus nephritis, for which she takes mycophenolate mofetil and low-dose prednisone. Her temperature is 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}), blood pressure is 105/65 mmHg105/65\text{ mmHg}, pulse is 124/min124/\text{min}, and respirations are 28/min28/\text{min}. Oxygen saturation is 86%86\% on room air. Physical examination reveals a pale, fatigued woman in moderate respiratory distress. Auscultation of the lungs reveals diffuse bilateral crackles. There is no jugular venous distension. Cardiac examination shows a regular tachycardia with no murmurs, rubs, or gallops. Trace bilateral pedal edema is present.

Laboratory results:
Laboratory TestResultReference Range
Hemoglobin7.2 g/dL7.2\text{ g/dL} (Baseline: 11.5 g/dL11.5\text{ g/dL})12.0−16.0 g/dL12.0 - 16.0\text{ g/dL}
Leukocyte count5,400/mm35,400/\text{mm}^34,500−11,000/mm34,500 - 11,000/\text{mm}^3
Platelet count140,000/mm3140,000/\text{mm}^3150,000−400,000/mm3150,000 - 400,000/\text{mm}^3
Blood urea nitrogen48 mg/dL48\text{ mg/dL}7−18 mg/dL7 - 18\text{ mg/dL}
Serum creatinine2.3 mg/dL2.3\text{ mg/dL} (Baseline: 1.4 mg/dL1.4\text{ mg/dL})0.6−1.2 mg/dL0.6 - 1.2\text{ mg/dL}
Arterial blood gas (room air):
ParameterResult
pH7.507.50
pCO2_226 mmHg26\text{ mmHg}
pO2_254 mmHg54\text{ mmHg}
HCO3−_3^-20 mEq/L20\text{ mEq/L}

Chest radiograph reveals new diffuse, bilateral patchy alveolar infiltrates. An emergency bedside echocardiogram demonstrates a left ventricular ejection fraction of 60%60\% with normal right ventricular function and no significant valvular abnormalities.

Which of the following diagnostic findings would most likely be seen on further evaluation of this patient?

Show answer & explanation

Answer: Progressively bloodier return on sequential aliquots of bronchoalveolar lavage fluid

Answer

Progressively bloodier return on sequential aliquots of bronchoalveolar lavage fluid
Diffuse alveolar hemorrhage (DAH) is a rare but life-threatening complication of systemic lupus erythematosus (SLE), particularly in patients with active lupus nephritis. The classic presentation includes dyspnea, fever, hemoptysis, and new bilateral alveolar infiltrates. The critical distinguishing feature in this vignette is the acute, profound drop in hemoglobin (from 11.5 to 7.2 g/dL), which indicates massive blood loss. Given the absence of gastrointestinal or other external bleeding, this internal blood loss must be localized to the pulmonary parenchyma. The gold standard for diagnosing DAH is bronchoscopy with bronchoalveolar lavage (BAL). In DAH, sequential aliquots of BAL fluid become progressively bloodier, confirming active alveolar bleeding rather than localized airway trauma from the procedure. Prompt recognition is critical as treatment requires high-dose corticosteroids and immunosuppressive therapy.

Step-by-Step Solution

1
Analyze the patient's vital signs and physical examination.
The patient is hypoxic, tachypneic, and tachycardic with bilateral lung crackles, indicating an acute pulmonary process.
To establish the primary organ system involved in the acute decompensation.
2
Evaluate the laboratory data and imaging.
Chest radiograph shows diffuse bilateral infiltrates. Labs reveal an acute drop in hemoglobin by 4.3 g/dL without signs of external bleeding. Echocardiogram is normal.
To differentiate between infectious, cardiogenic, and hemorrhagic causes of pulmonary infiltrates.
3
Synthesize the findings with the patient's medical history.
A patient with active SLE (lupus nephritis) presenting with new pulmonary infiltrates, hemoptysis, and massive unexplained anemia is highly suspicious for diffuse alveolar hemorrhage (DAH).
To formulate the most likely diagnosis based on the clinical triad.
4
Identify the diagnostic gold standard for the suspected condition.
Bronchoscopy with bronchoalveolar lavage (BAL) showing progressively bloody aliquots confirms DAH.
To answer the specific question asked in the stem regarding further evaluation findings.

Key Concept

Diffuse alveolar hemorrhage in systemic lupus erythematosus is characterized by the triad of hemoptysis, diffuse pulmonary infiltrates, and an acute drop in hemoglobin. Bronchoscopy with serial bronchoalveolar lavage confirms the diagnosis.
Question 1130Question →

Match each patient's clinical presentation with the most appropriate initial pharmacological intervention.

Click a left item, then click its matching right item

Items

A 45-year-old man with a 10-year atherosclerotic cardiovascular disease (ASCVD) risk of 22% and an LDL cholesterol of 145 mg/dL
A 50-year-old woman with newly diagnosed type 2 diabetes mellitus, a hemoglobin A1c of 7.8%, and normal renal function
A 60-year-old man with newly diagnosed primary hypertension and osteoporosis, with no history of diabetes or heart failure
A 55-year-old woman with chronic kidney disease, severe albuminuria, and newly diagnosed primary hypertension

Matches

Show answer & explanation

Answer

The correct matches pair each specific clinical presentation with its guideline-directed first-line pharmacological therapy.
Each correct pairing reflects the standard of care for initial pharmacological management in primary care: statins for high ASCVD risk, biguanides for uncomplicated type 2 diabetes, thiazides for hypertension with osteoporosis, and ACE inhibitors for hypertension with proteinuric CKD.

Step-by-Step Solution

1
Analyze the lipid profile and ASCVD risk.
Identify the indication for a high-intensity statin.
Current guidelines recommend high-intensity statin therapy for primary prevention in patients with a 10-year ASCVD risk of 20% or higher.
2
Analyze the new diabetes diagnosis.
Identify the indication for metformin.
A biguanide is the established first-line agent for newly diagnosed type 2 diabetes mellitus.
3
Analyze the hypertension case with comorbid osteoporosis.
Identify the indication for a thiazide diuretic.
Thiazides promote renal calcium reabsorption, improving bone mineral density while effectively lowering blood pressure.
4
Analyze the hypertension case with comorbid CKD and albuminuria.
Identify the indication for an ACE inhibitor.
ACE inhibitors reduce intraglomerular pressure, specifically slowing the progression of proteinuric kidney disease.

Key Concept

First-line pharmacological management of common outpatient chronic diseases
Question 1131Question →

A 54-year-old man is brought to the emergency department by his partner due to a 24-hour history of severe headache, high fever, and worsening confusion. He has a history of advanced HIV infection and has been non-adherent to his antiretroviral therapy. His temperature is 39.4°C (102.9°F), blood pressure is 105/65 mmHg, and heart rate is 118/min. He is lethargic and oriented only to person. Physical examination is notable for marked resistance to passive neck flexion. Fundoscopic evaluation reveals blurring of the optic disc margins bilaterally. Arrange the following diagnostic and therapeutic interventions in the most appropriate chronological order for the immediate management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of interventions is: 1) Draw peripheral blood cultures, 2) Administer empiric intravenous antibiotics and dexamethasone, 3) Obtain a non-contrast CT scan of the head, and 4) Perform a lumbar puncture.
The standard sequence for managing suspected bacterial meningitis with indications for a CT head prior to a lumbar puncture is: Blood cultures -> Empiric antibiotics -> CT head -> Lumbar puncture. Blood cultures are drawn first so they are not sterilized by antibiotics. Antibiotics are given immediately next because treatment delays are fatal. CT head is done next to rule out a space-occupying lesion due to the patient's 'red flag' symptoms (HIV, confusion, papilledema). Finally, a lumbar puncture is safely performed once mass effect is ruled out.

Step-by-Step Solution

1
Draw peripheral blood cultures
Blood samples are secured for microbial growth before sterilization occurs.
Administering antibiotics prior to drawing blood cultures can sterilize the blood and prevent the identification of the causative organism.
2
Administer empiric intravenous antibiotics and dexamethasone
Broad-spectrum coverage and anti-inflammatory therapy are initiated.
Bacterial meningitis is a rapidly progressive and highly fatal disease; empiric therapy must be started immediately and never delayed for imaging or lumbar puncture.
3
Obtain a non-contrast CT scan of the head
Cranial imaging rules out mass effect, midline shift, or a space-occupying lesion.
The patient has papilledema, altered mental status, and is severely immunocompromised, placing him at high risk for intracranial pathology (e.g., toxoplasmosis, primary CNS lymphoma) that could cause herniation if a lumbar puncture is performed blindly.
4
Perform a lumbar puncture for cerebrospinal fluid analysis
Cerebrospinal fluid is obtained for Gram stain, culture, and specific antigen testing.
Once mass effect is ruled out by the CT scan, it is safe to proceed with the definitive diagnostic test to tailor long-term antimicrobial therapy.

Key Concept

The chronological management of suspected bacterial meningitis in patients requiring neuroimaging prior to lumbar puncture.
Question 1132Question →

For each of the following classic clinical presentations of infectious diseases, select the most appropriate first-line targeted antimicrobial therapy.

Click a left item, then click its matching right item

Items

A 20-year-old male notes a single, indurated, painless ulcer on his glans penis. He has bilateral rubbery inguinal lymph nodes. Point-of-care darkfield microscopy shows spirochetes.
A 22-year-old female college student complains of painful urination and increased urinary frequency for two days. She is afebrile and has no costovertebral angle tenderness.
A 54-year-old male develops a 10-cm annular rash with central clearing on his lower extremity two weeks after a camping trip in Connecticut.
A 32-year-old female presents with a profuse, malodorous, yellow-green vaginal discharge and vulvar irritation. Wet mount microscopy reveals motile, flagellated protozoa.

Matches

Show answer & explanation

Answer

Primary syphilis matches with intramuscular benzathine penicillin G. Uncomplicated acute cystitis matches with oral nitrofurantoin. Early localized Lyme disease matches with oral doxycycline. Trichomoniasis matches with oral metronidazole.
Each specific clinical scenario presents classic pathognomonic signs of an infectious disease that corresponds directly to a well-established, first-line antimicrobial therapy per current medical guidelines.

Step-by-Step Solution

1
Analyze the first clinical vignette to identify the underlying pathogen or disease state.
The painless chancre and spirochetes indicate primary syphilis.
Accurate diagnosis is required to select the correct targeted antimicrobial.
2
Identify the standard first-line therapy for the diagnosed condition.
Primary syphilis is treated with intramuscular benzathine penicillin G.
Treatment guidelines dictate specific regimens to ensure efficacy and prevent complications.
3
Repeat the diagnostic and therapeutic pairing process for the remaining vignettes.
Cystitis pairs with nitrofurantoin; Lyme disease pairs with doxycycline; Trichomoniasis pairs with metronidazole.
Each distinct presentation requires a specific targeted agent.

Key Concept

First-line empiric and targeted antimicrobial therapies for classic infectious disease presentations.
Estimated Time:1m 30s
Question 1133Question →

Match each clinical presentation of infective endocarditis or severe bacteremia to its most appropriate targeted antimicrobial regimen.

Click a left item, then click its matching right item

Items

Prosthetic aortic valve (placed 3 months ago) endocarditis growing methicillin-resistant Staphylococcus epidermidis (MRSE)
Native mitral valve endocarditis growing Enterococcus faecalis in a patient with stage 3 chronic kidney disease
Native tricuspid valve endocarditis growing methicillin-susceptible Staphylococcus aureus (MSSA) currently on empiric vancomycin
Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with a rapidly rising serum creatinine on day 4 of vancomycin therapy

Matches

Show answer & explanation

Answer

Prosthetic valve MRSE matches with Vancomycin/Rifampin/Gentamicin. E. faecalis with CKD matches with Ampicillin/Ceftriaxone. MSSA matches with Cefazolin. MRSA with nephrotoxicity matches with Daptomycin.
Each correct pairing aligns with infectious disease guidelines: staphylococcal prosthetic valves require rifampin and gentamicin adjuncts; MSSA strictly requires beta-lactam de-escalation; enterococcal endocarditis with renal impairment requires aminoglycoside-sparing dual beta-lactams; and vancomycin-induced nephrotoxicity necessitates a switch to daptomycin.

Step-by-Step Solution

1
Analyze the prosthetic valve endocarditis case (MRSE).
Identify the need for biofilm penetration.
Staphylococcal infections of prosthetic material develop robust biofilms. Rifampin is required to penetrate the biofilm, but it cannot be used alone due to rapid resistance. It must be combined with vancomycin (for MRSE) and gentamicin (for early synergy).
2
Analyze the E. faecalis endocarditis case with chronic kidney disease.
Select a synergistic regimen that spares the kidneys.
Enterococcal endocarditis requires synergy. While ampicillin plus gentamicin is traditional, ampicillin plus ceftriaxone achieves synergy through dual penicillin-binding protein inhibition and completely avoids nephrotoxic aminoglycosides.
3
Evaluate the MSSA endocarditis case on empiric vancomycin.
Determine the optimal definitive therapy.
Vancomycin is inferior to anti-staphylococcal penicillins (nafcillin) or first-generation cephalosporins (cefazolin) for MSSA. Standard antimicrobial stewardship dictates de-escalation to cefazolin.
4
Assess the MRSA bacteremia case complicated by acute kidney injury.
Choose a bactericidal agent active against MRSA with a different toxicity profile.
Vancomycin is notoriously nephrotoxic. Daptomycin is highly bactericidal against MRSA and is not nephrotoxic, making it the ideal switch when acute kidney injury occurs.

Key Concept

Targeted antimicrobial therapy for bacteremia and endocarditis requires adjustment based on pathogen susceptibility (e.g., MRSA vs. MSSA), infection site (prosthetic biofilm vs. native valve), and patient-specific toxicities (nephrotoxicity).
Question 1134Question →

A 42-year-old woman with a 3-year history of diffuse cutaneous systemic sclerosis comes to the emergency department due to a severe headache and blurred vision that began 24 hours ago. Her temperature is 37.0°C (98.6°F), blood pressure is 218/116 mm Hg, and pulse is 92/min. Physical examination shows tight, thickened skin over the face, trunk, and extremities. Laboratory studies show a serum creatinine of 2.9 mg/dL (baseline 0.9 mg/dL) and a hemoglobin of 10.2 g/dL. A peripheral blood smear reveals numerous schistocytes. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administration of captopril

Answer

Administration of captopril
This patient's presentation of acute malignant hypertension, acute kidney injury, and microangiopathic hemolytic anemia in the setting of diffuse cutaneous systemic sclerosis is the classic description of Scleroderma Renal Crisis (SRC). The underlying pathophysiology involves thickening of the renal arcuate and interlobular arteries, leading to decreased renal perfusion, massive renin release, and subsequent severe hypertension. The cornerstone of life-saving therapy is the prompt administration of an angiotensin-converting enzyme (ACE) inhibitor, classically captopril. ACE inhibitors directly block the maladaptive renin-angiotensin-aldosterone system cascade, relieving renal vasoconstriction.

Step-by-Step Solution

1
Identify the primary clinical syndrome from the patient's presentation.
The patient has systemic sclerosis and presents with new-onset malignant hypertension, acute kidney injury, and microangiopathic hemolytic anemia (schistocytes).
These findings form the classic triad of Scleroderma Renal Crisis (SRC).
2
Determine the optimal initial treatment for this specific condition.
ACE inhibitors (such as captopril) are the primary intervention.
SRC is driven by extreme activation of the renin-angiotensin-aldosterone system due to renal vascular damage. ACE inhibitors directly counteract this mechanism.

Key Concept

Scleroderma Renal Crisis (SRC) presents with malignant hypertension and oliguric acute renal failure in a patient with systemic sclerosis; the primary treatment is immediate initiation of an ACE inhibitor.
Estimated Time:45s
Question 1135Question →

A 68-year-old man comes to the emergency department complaining of progressive shortness of breath and an increasingly productive cough over the last 3 days. He notes his sputum has changed from clear to thick and yellowish-green. His medical history is significant for chronic obstructive pulmonary disease (COPD) and a 45-pack-year smoking history. Temperature is 37.6°C (99.7°F), blood pressure is 138/86 mmHg, pulse is 92/min, and respiratory rate is 22/min. Oxygen saturation is 89% on room air. Physical examination reveals a barrel-shaped chest with diffuse bilateral expiratory wheezing and a prolonged expiratory phase. Jugular venous pressure is normal, and there is no lower extremity edema. A bedside chest radiograph demonstrates hyperinflated lungs with flattened diaphragms, but no focal consolidations, pleural effusions, or cardiomegaly. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer inhaled bronchodilators, systemic corticosteroids, and an oral macrolide antibiotic

Answer

The most appropriate next step is to administer inhaled bronchodilators, systemic corticosteroids, and an oral macrolide antibiotic.
The correct answer includes the three mainstays of therapy for an acute exacerbation of chronic obstructive pulmonary disease (COPD) with infectious signs: inhaled bronchodilators (e.g., albuterol and ipratropium), systemic corticosteroids (e.g., oral prednisone), and a targeted antibiotic (e.g., azithromycin or doxycycline). This patient presents with the classic cardinal symptoms of a COPD exacerbation (increased dyspnea, increased sputum volume, and increased sputum purulence). The presence of purulent sputum specifically dictates the need for antibiotic therapy to cover common respiratory pathogens (such as Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis).

Step-by-Step Solution

1
Analyze the patient's clinical presentation and vital signs.
The patient has increased dyspnea, increased sputum volume, and increased sputum purulence (changing to yellowish-green) in the setting of chronic COPD.
Identifying the three cardinal symptoms of an acute exacerbation of COPD determines the need for comprehensive medical therapy.
2
Rule out alternative causes of acute dyspnea using physical exam and imaging.
Heart failure is highly unlikely due to the normal jugular venous pressure, absence of peripheral edema, and a chest radiograph showing only hyperinflation without cardiomegaly or effusions.
Differentiating between a primary pulmonary etiology and a cardiovascular one ensures targeted therapy and avoids harmful interventions like unnecessary diuresis.
3
Determine the appropriate therapeutic interventions based on established guidelines.
Select short-acting bronchodilators, systemic corticosteroids, and targeted, narrow-spectrum antibiotics.
Standard of care for a moderate to severe COPD exacerbation with purulent sputum requires all three modalities to reduce airway inflammation, relieve bronchospasm, and treat the underlying bacterial trigger.

Key Concept

Management of Acute Exacerbation of COPD
Question 1136Question →

A 5454-year-old man undergoing induction chemotherapy for acute myeloid leukemia presents to the emergency department with a new-onset fever of 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}) and chills. He has an indwelling central venous catheter. His blood pressure is 105/65 mm Hg105/65 \text{ mm Hg}, heart rate is 112/min112/\text{min}, and respiratory rate is 18/min18/\text{min}. Physical examination reveals no obvious source of infection, and the catheter site appears clean without erythema or fluctuance. Laboratory studies demonstrate an absolute neutrophil count of 200/μL200/\mu\text{L}. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Obtain blood cultures, 2) Administer empiric antibiotics within 60 minutes, 3) Obtain a chest radiograph and complete the diagnostic workup, 4) Reassess clinical response and cultures at 48-72 hours, and 5) Discontinue antibiotics upon neutrophil recovery.
The precise chronological management of febrile neutropenia is designed to minimize mortality. Blood cultures must be drawn first to avoid sterilization. Because delays in therapy significantly increase mortality, empiric antipseudomonal antibiotics must be administered next, strictly within 6060 minutes of triage. Consequently, diagnostic imaging such as a chest radiograph must follow, rather than precede, antibiotic administration. Patients are reassessed at 4848-7272 hours when preliminary cultures result, and antibiotics are ultimately discontinued only when the patient has been afebrile for 4848 hours and the absolute neutrophil count is ≥500/μL\geq 500/\mu\text{L}.

Step-by-Step Solution

1
Recognize the clinical emergency
Identify that the patient has high-risk febrile neutropenia (ANC <500/μL< 500/\mu\text{L}).
Febrile neutropenia carries a high risk of rapid clinical deterioration and death if not treated emergently.
2
Prioritize microbiological sampling
Draw at least two sets of blood cultures (central and peripheral).
Cultures must be obtained before antibiotics to ensure the highest probability of identifying the causative pathogen.
3
Initiate life-saving therapy
Administer broad-spectrum antipseudomonal antibiotics.
Antibiotics must be given within 6060 minutes of presentation. Delays to perform imaging or other procedures are strictly contraindicated.
4
Complete the diagnostic workup
Perform a chest radiograph and other directed tests.
Imaging helps identify a localized source of infection but must logically and safely follow the administration of empiric therapy.
5
Reassess and plan for de-escalation
Review cultures at 4848-7272 hours and eventually stop antibiotics only when ANC is ≥500/μL\geq 500/\mu\text{L} and the patient is afebrile.
This strategy ensures appropriate duration of coverage while preventing premature cessation that could lead to fatal relapse.

Key Concept

Febrile neutropenia is an infectious disease emergency requiring blood cultures followed immediately by empiric antipseudomonal antibiotics (within 6060 minutes), prior to any imaging studies. Therapy is continued until neutrophil recovery (ANC ≥500/μL\geq 500/\mu\text{L}).
Question 1137Question →

As part of an introductory hematopathology module, a medical trainee is asked to correlate microscopic cellular abnormalities with their corresponding disease states. Match each classic peripheral blood smear description with the diagnosis it most strongly suggests.

Click a left item, then click its matching right item

Items

Hypersegmented neutrophils
Auer rods
Smudge cells
Schistocytes

Matches

Show answer & explanation

Answer

Hypersegmented neutrophils match with Megaloblastic anemia; Auer rods match with Acute myeloid leukemia; Smudge cells match with Chronic lymphocytic leukemia; Schistocytes match with Microangiopathic hemolytic anemia.
Each classic morphological finding directly corresponds to the underlying pathophysiology of a specific hematologic disorder: impaired DNA synthesis yields hypersegmented neutrophils, abnormal myeloblast granulation produces Auer rods, clonal fragile B-cells manifest as smudge cells, and intravascular mechanical shearing creates schistocytes.

Step-by-Step Solution

1
Identify the cellular origin and pathophysiology of hypersegmented neutrophils.
Linked to impaired DNA synthesis affecting myeloid maturation, specifically pointing to Megaloblastic anemia.
Vitamin B12 and folate are required for normal DNA synthesis; deficiency leads to nuclear-cytoplasmic asynchrony.
2
Recognize the clinical significance of Auer rods.
Matched with Acute myeloid leukemia.
Auer rods confirm the myeloblastic lineage of the leukemic cells, ruling out lymphoblastic leukemias.
3
Recall the conditions associated with fragile white blood cells that rupture on smear preparation (smudge cells).
Matched with Chronic lymphocytic leukemia.
CLL is characterized by a monoclonal proliferation of incompetent, structurally fragile B lymphocytes.
4
Determine the mechanism behind red blood cell fragmentation (schistocytes).
Matched with Microangiopathic hemolytic anemia.
Intravascular shearing by microthrombi (as in TTP, HUS, or DIC) produces these distinct fragmented shapes.

Key Concept

Recognition of pathognomonic peripheral blood smear findings is a foundational diagnostic skill in hematology that directly guides subsequent clinical workup.
Estimated Time:45s
Question 1138Question →

A 3535-year-old man presents to the emergency department with a 33-day history of increasing fatigue, spontaneous gum bleeding, and a diffuse petechial rash. He has no significant past medical history and takes no medications. Vital signs are temperature 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), heart rate 105/min105/\text{min}, blood pressure 110/70 mmHg110/70\text{ mmHg}, and respiratory rate 18/min18/\text{min}. Physical examination reveals pale conjunctivae, continuous oozing from the gingival margins, diffuse petechiae on the lower extremities, and large ecchymoses on the trunk. There is no hepatosplenomegaly or lymphadenopathy.

Laboratory results are as follows:

Laboratory TestResultReference Range
Hemoglobin8.2 g/dL8.2\text{ g/dL}13.5−17.5 g/dL13.5-17.5\text{ g/dL}
Platelets18,000/mm318,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
Leukocytes2,500/mm32,500/\text{mm}^34,500−11,000/mm34,500-11,000/\text{mm}^3
Prothrombin time (PT)22 sec22\text{ sec}11−15 sec11-15\text{ sec}
Partial thromboplastin time (PTT)55 sec55\text{ sec}25−40 sec25-40\text{ sec}
Fibrinogen85 mg/dL85\text{ mg/dL}200−400 mg/dL200-400\text{ mg/dL}
D-dimer5,400 ng/mL5,400\text{ ng/mL}<500 ng/mL< 500\text{ ng/mL}

A peripheral blood smear reveals numerous large, atypical mononuclear cells with abundant cytoplasm containing multiple primary granules and prominent needle-like cytoplasmic inclusions.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administration of all-trans retinoic acid

Answer

Administration of all-trans retinoic acid
This patient's presentation of pancytopenia, spontaneous mucosal bleeding, and a peripheral smear demonstrating numerous large mononuclear cells with prominent needle-like cytoplasmic inclusions (Auer rods) is highly suspicious for Acute Promyelocytic Leukemia (APL). APL, the M3 subtype of acute myeloid leukemia, is notorious for presenting with a life-threatening bleeding diathesis due to severe Disseminated Intravascular Coagulation (DIC). The leukemic promyelocytes contain primary granules rich in tissue factor and other procoagulants; when these cells turn over or are destroyed, the release of these factors triggers massive activation of the coagulation cascade. This is confirmed by the patient's markedly prolonged PT and PTT, hypofibrinogenemia, and elevated D-dimer. APL is a true oncologic emergency characterized by a high early mortality rate, primarily from intracranial or pulmonary hemorrhage. The most critical step in management is the immediate administration of all-trans retinoic acid (ATRA). ATRA overcomes the differentiation block caused by the characteristic PML−RARAPML-RARA fusion gene (a result of the t(15;17)t(15;17) translocation), allowing the malignant promyelocytes to mature into functional neutrophils. This differentiation rapidly halts the release of procoagulants and resolves the DIC. Crucially, ATRA must be initiated empirically the moment APL is suspected based on clinical features and peripheral smear findings; treatment must never be delayed to wait for confirmatory bone marrow biopsy or cytogenetic results.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient exhibits severe, spontaneous mucosal and cutaneous bleeding (oozing gums, petechiae, ecchymoses) in an acute setting.
Bleeding diathesis narrows the differential to platelet disorders, coagulation factor deficiencies, or a consumptive process.
2
Interpret the laboratory and peripheral smear data.
Labs show pancytopenia, marked prolongation of PT and PTT, severe hypofibrinogenemia, and markedly elevated D-dimer. The smear shows atypical cells with needle-like inclusions (Auer rods).
The abnormal coagulation panel with low fibrinogen and high D-dimer confirms Disseminated Intravascular Coagulation (DIC). The smear findings are pathognomonic for Acute Promyelocytic Leukemia (APL).
3
Determine the pathogenesis of the current emergency.
The abnormal promyelocytes in APL are filled with primary granules that contain procoagulants (like tissue factor). The release of these contents heavily activates the coagulation cascade, driving the catastrophic DIC.
Understanding the driver of the DIC dictates that treating the underlying leukemia is the most effective way to stop the coagulopathy.
4
Select the most appropriate immediate intervention.
All-trans retinoic acid (ATRA) must be administered immediately.
ATRA forces the malignant promyelocytes to differentiate into mature neutrophils, abruptly halting the release of procoagulants. It should be given immediately upon clinical suspicion, prior to genetic confirmation of the t(15;17)t(15;17) translocation.

Key Concept

Acute Promyelocytic Leukemia (APL) is a medical emergency that frequently presents with severe Disseminated Intravascular Coagulation (DIC). Upon clinical or morphologic suspicion (e.g., Auer rods on smear), all-trans retinoic acid (ATRA) must be initiated immediately to prevent fatal hemorrhage.
Estimated Time:1m 30s
Question 1139Question →

A 53-year-old woman is brought to the emergency department by her husband due to a severe headache, blurred vision, and progressive confusion over the past 24 hours. Her past medical history is significant for diffuse cutaneous systemic sclerosis diagnosed three years ago. Two weeks ago, she was started on oral prednisone for worsening joint pain and skin tightness. Her temperature is 37.1°C (98.8°F), blood pressure is 225/115 mmHg, and pulse is 102/min. Physical examination shows thickened, tight skin over her face, forearms, and chest. Neurological examination reveals a confused patient but is negative for focal motor or sensory deficits. Fundoscopy demonstrates bilateral flame-shaped hemorrhages and papilledema. Laboratory studies show:

TestResult
Hemoglobin9.1 g/dL
Platelets85,000/mm³
Leukocytes8,400/mm³
Creatinine3.2 mg/dL

A peripheral blood smear demonstrates 3-5 schistocytes per high-power field. Her baseline creatinine one month ago was 0.8 mg/dL. Which of the following is the most appropriate next step in the pharmacologic management of this patient's condition?

Show answer & explanation

Answer: Oral captopril

Answer

Oral captopril
The correct answer is oral captopril. This patient is presenting with Scleroderma Renal Crisis (SRC), a severe and potentially fatal complication that occurs in about 10-15% of patients with diffuse cutaneous systemic sclerosis. SRC is characterized by the sudden onset of marked hypertension (often malignant, presenting with end-organ damage such as encephalopathy and papilledema) and rapidly progressive oliguric acute kidney injury. Approximately half of patients also develop microangiopathic hemolytic anemia (MAHA) and thrombocytopenia, as seen in this patient with schistocytes on her blood smear. A major known trigger for SRC is the recent use of moderate-to-high dose corticosteroids (e.g., prednisone), which this patient recently started taking. The pathogenesis of SRC involves acute intimal proliferation and narrowing of the renal arteries, leading to decreased renal perfusion, massive renin release, and severe activation of the renin-angiotensin-aldosterone system (RAAS). Therefore, the specific and life-saving treatment is rapid RAAS blockade with a short-acting ACE inhibitor, such as oral captopril. Captopril should be initiated immediately and titrated to carefully lower the blood pressure. Notably, ACE inhibitors are the treatment of choice for SRC even in the setting of acute kidney injury, a situation where they are typically contraindicated in other disease states.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and medical history.
The patient has diffuse cutaneous systemic sclerosis and presents with new-onset malignant hypertension, encephalopathy, acute kidney injury, and microangiopathic hemolytic anemia.
Identifying the classic triad of malignant hypertension, rapidly progressive acute renal failure, and systemic sclerosis establishes the primary clinical syndrome.
2
Synthesize the laboratory findings with the clinical picture.
The presence of schistocytes, thrombocytopenia, and elevated creatinine confirms Scleroderma Renal Crisis (SRC), which was likely precipitated by her recent initiation of corticosteroid therapy.
Differentiating SRC from primary thrombotic microangiopathies (like thrombotic thrombocytopenic purpura) is critical for selecting the correct physiological target for treatment.
3
Determine the most appropriate pharmacologic intervention based on pathophysiology.
Immediate administration of a short-acting ACE inhibitor (captopril) is required.
SRC is driven by massive, unabated renin-angiotensin-aldosterone system (RAAS) activation; ACE inhibitors specifically reverse this intense vasospasm and are the only agents proven to restore renal perfusion and improve outcomes.

Key Concept

Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis characterized by malignant hypertension, acute kidney injury, and often microangiopathic hemolytic anemia. It is treated primarily with ACE inhibitors (e.g., captopril) despite the presence of renal failure.
Estimated Time:1m 30s
Question 1140Question →

A physician is evaluating a hospitalized patient with chronic kidney disease who has developed anuria and profound muscle weakness over the past twelve hours. An electrocardiogram demonstrates prolonged PR intervals, widened QRS complexes, and tall, peaked T waves. A point-of-care basic metabolic panel reveals a serum potassium level of 7.47.4 mEq/L. Arrange the following therapeutic interventions in the most appropriate chronological order of administration for this patient's acute management.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Intravenous calcium gluconate, 2) Intravenous regular insulin and dextrose, 3) Oral sodium zirconium cyclosilicate.
The fundamental treatment algorithm for severe hyperkalemia with electrocardiographic changes prioritizes immediate survival over actual potassium removal. Intravenous calcium gluconate works within 1 to 3 minutes to stabilize the resting membrane potential of cardiac myocytes, making it the mandatory first step. Next, intravenous regular insulin with dextrose acts within 15 to 30 minutes to push potassium inside the cells, providing a rapid but temporary drop in serum potassium. Finally, because the total body potassium remains elevated, a definitive removal method such as oral sodium zirconium cyclosilicate (a gastrointestinal potassium binder) is given, though its slow onset of action (hours) makes it inappropriate for acute cardiac stabilization.

Step-by-Step Solution

1
Identify the primary immediate threat to the patient's life.
The patient has severe hyperkalemia (7.47.4 mEq/L) with significant electrocardiogram changes, placing the patient at imminent risk of ventricular fibrillation or asystole.
Recognizing the acute cardiac risk dictates that the very first intervention must directly protect the heart.
2
Select the agent for cardiac membrane stabilization.
Intravenous calcium gluconate is identified as the first-line therapy.
Calcium directly antagonizes the membrane actions of potassium without actually lowering the serum potassium level, acting within minutes to stabilize the myocardium.
3
Select the agent for rapid intracellular shifting of potassium.
Intravenous regular insulin (with dextrose to prevent hypoglycemia) is chosen next.
Once the heart is protected, potassium must be rapidly cleared from the serum. Insulin drives potassium into cells, temporarily lowering serum levels within 15 to 30 minutes.
4
Select the agent for definitive total-body potassium elimination.
Oral sodium zirconium cyclosilicate (a gastrointestinal cation exchanger) is scheduled last.
Shifting agents only hide potassium inside cells. A binder or dialytic therapy is required to permanently excrete the potassium, but this process takes hours to work.

Key Concept

The algorithmic management of acute, severe hyperkalemia with electrocardiographic changes always follows a strict three-step chronological sequence: cardiac membrane stabilization (calcium), intracellular shifting (insulin/dextrose, albuterol), and definitive total-body elimination (gastrointestinal binders, diuretics, or dialysis).
Estimated Time:45s
PreviousPage 57 / 158Next
Internal Medicine Practice Questions — USMLE Step 2 CK — Page 57 | Examkin